Bakhu enters $600k compliance funding MoU with Phytocyte
Bakhu Holdings Corp. signed a $600,000 non-interest convertible note with Phytocyte to restore compliance. The deal proposes transferring 70% of share capital, signaling significant corporate restructuring.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day